Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $18.0250 (3.71%) ($18.0250 - $18.1000) on Thu. Dec. 2, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.38% (three month average) | RSI | 57 | Latest Price | $18.0250(3.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.2% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKK(47%) IBB(47%) ARKG(46%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.69% in a week (0% probabilities). VIXM(-40%) VXX(-28%) UNG(-16%) TLT(-11%) USO(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.69% (StdDev 3.38%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $17.74(1.61%) | 10 Day Moving Average | $17.93(0.53%) | 20 Day Moving Average | $17.88(0.81%) | To recent high | -9.4% | To recent low | 22.7% | Market Cap | $1.339b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |